(Q37953268)

25 August 2017

Projected and observed diabetes epidemics in China and beyond (English)

1 reference

25 August 2017

Dong Zhao

1

1 reference

25 August 2017

Fan Zhao

series ordinal

2

1 reference

25 August 2017

Yan Li

series ordinal

3

1 reference

25 August 2017

Zheng Zheng

series ordinal

4

1 reference

25 August 2017

1 February 2012

1 reference

Current cardiology reports

25 August 2017

1 reference

25 August 2017

14

1 reference

25 August 2017

1

1 reference

25 August 2017

106-111

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-011-0227-9

25 August 2017

0 references

cites work

Global estimates of the prevalence of diabetes for 2010 and 2030

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Prevalence of diabetes among men and women in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Overview of obesity in Mainland China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Prevalence and association between obesity and metabolic syndrome among Chinese elementary school children: a school-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-011-0227-9

Diabetes care in China: meeting the challenge

21 January 2018

1 reference

12 December 2020

[Study on the epidemiological characteristics of diabetes mellitus and IGT in China]

1 reference

12 December 2020

Prevalence of diabetes and impaired fasting glucose in Chinese adults, China National Nutrition and Health Survey, 2002.

1 reference

12 December 2020

Epidemiological study on diabetes mellitus in Chinese children and adolescents at the age of 5 to 17 years

1 reference

12 December 2020

A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China (author's transl)

1 reference

12 December 2020

Burden of diabetes in the adult Chinese population: A systematic literature review and future projections

1 reference

12 December 2020

Incidence of NIDDM in Daqing and forecasting of NIDDM in China in 21st century

1 reference

12 December 2020

10.1007/S11886-011-0227-9

Identifiers

DOI

1 reference

25 August 2017

1 reference